Home | Faculty/Staff | Innovation & Technology Transfer (OITT)

Office of Innovation & Technology Transfer


The primary mission of the Office of Innovation & Technology Transfer (OITT) is to facilitate the development, dissemination, protection, transfer, licensing, and commercialization of technology, inventions, and creations developed by professors, staff, and students at Oregon Tech in order to benefit the public.


The OITT is responsible for managing the intellectual property assets of Oregon Institute of Technology. Our objective is to promote the transfer of Oregon Tech technology for society’s use and benefit, while generating income to provide for continued support of applied research and education. The OITT serves in a support role to OREC, academic departments, and the university at large in all matters involving intellectual property.

OITT responsibilities include the following functions, activities, and services:

  1. Supporting and providing educational training to faculty, staff, and students regarding intellectual property.
  2. Assisting faculty and staff in writing invention disclosures.
  3. Supporting OREC, the Office of Strategic Partnerships, and Oregon Tech’s departments in matters involving intellectual property, including helping structure corporate sponsored applied research agreements.
  4. Receiving invention disclosures from faculty, staff, and students.
  5. Evaluating invention disclosures for their commercial and licensing possibilities.
  6. Administration of the preparation, filing, and prosecution of national & international patent applications.
  7. Developing licensing strategies for OIT’s intellectual property assets.
  8. Managing and monitoring of existing license agreements.
  9. Developing IP strategy and managing intellectual capital of Oregon Tech.

Philosophy & Licensing Social Responsibility

OITT is committed to socially responsible licensing, and endorses the “In the Public Interest: Nine Points to Consider in Licensing University Technology” document which recommends that we consider including provisions that address unmet needs, such as those of neglected patient populations or geographic areas, giving particular attention to improved therapeutics, diagnostics, and agricultural technologies for the developing world.